Addus HomeCare (ADUS) Financials

$99.24 -2.93 (-2.87%)

Closing price 04:00 PM Eastern

Extended Trading

$99.30 +0.06 (+0.06%)

As of 05:07 PM Eastern

Annual Income Statements for Addus HomeCare

This table shows Addus HomeCare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	12	12	12	12	16	25	33	45	46	63	74
Consolidated Net Income / (Loss)	12	12	12	12	16	25	33	45	46	63	74
Net Income / (Loss) Continuing Operations	12	11	12	12	16	26	33	45	46	63	74
Total Pre-Tax Income	17	15	16	21	20	33	42	60	60	81	99
Total Operating Income	18	16	15	25	23	35	45	66	69	91	103
Total Gross Profit	84	87	99	116	137	179	226	270	300	340	375
Total Revenue	313	337	401	426	517	649	765	864	951	1,059	1,155
Operating Revenue	313	337	401	426	517	649	765	864	951	1,059	1,155
Total Cost of Revenue	229	250	302	310	380	470	539	595	651	719	780
Operating Cost of Revenue	229	245	295	310	380	470	539	595	651	719	780
Total Operating Expenses	66	71	83	91	114	144	182	204	231	249	272
Selling, General & Admin Expense	62	66	77	77	105	134	170	189	217	235	259
Depreciation Expense	3.83	4.72	6.65	6.66	8.64	11	12	14	14	14	14
Total Other Income / (Expense), net	-0.68	-0.74	0.69	-4.19	-2.42	-1.58	-2.57	-5.54	-8.57	-9.63	-3.34
Interest Expense	0.70	0.79	2.33	4.47	5.02	3.11	3.19	5.81	8.91	11	7.73
Interest & Investment Income	0.02	0.05	2.81	0.07	2.59	1.52	0.62	0.27	0.34	1.48	4.39
Income Tax Expense	5.43	3.93	4.10	9.26	4.10	7.36	8.81	15	14	19	26
Basic Earnings per Share	$1.12	$1.06	$1.07	$1.04	$1.36	$1.83	$2.12	$2.87	$2.90	$3.91	$4.33
Weighted Average Basic Shares Outstanding	10.90M	10.99M	11.29M	11.47M	12.05M	13.82M	15.60M	15.74M	15.86M	16.00M	17.01M
Diluted Earnings per Share	$1.10	$1.04	$1.07	$1.03	$1.33	$1.77	$2.08	$2.81	$2.84	$3.83	$4.23
Weighted Average Diluted Shares Outstanding	11.11M	11.19M	11.35M	11.62M	12.38M	14.25M	15.96M	16.06M	16.18M	16.31M	17.38M
Weighted Average Basic & Diluted Shares Outstanding	10.90M	11M	11.30M	11.50M	12.10M	13.82M	15.60M	15.95M	16.13M	16.23M	18.17M

This table shows Addus HomeCare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	12	15	13	15	15	20	16	18	20	20
Consolidated Net Income / (Loss)	12	15	13	15	15	20	16	18	20	20
Net Income / (Loss) Continuing Operations	12	15	13	15	15	20	16	18	20	20
Total Pre-Tax Income	15	18	16	19	20	25	21	25	27	26
Total Operating Income	18	21	19	22	23	28	24	26	26	27
Total Gross Profit	75	79	78	82	87	92	88	93	92	101
Total Revenue	240	247	252	260	271	276	281	287	290	297
Operating Revenue	240	247	252	260	271	276	281	287	290	297
Total Cost of Revenue	165	168	173	178	184	184	193	194	198	196
Operating Cost of Revenue	165	168	173	178	184	184	193	194	198	196
Total Operating Expenses	58	58	60	61	64	64	65	67	66	75
Selling, General & Admin Expense	54	54	56	57	60	61	61	64	63	71
Depreciation Expense	3.44	3.49	3.45	3.38	3.62	3.68	3.47	3.40	3.45	3.21
Total Other Income / (Expense), net	-2.39	-2.54	-2.36	-2.04	-2.62	-2.62	-2.34	-1.64	1.34	-0.70
Interest Expense	2.47	2.63	2.46	2.33	3.20	3.12	2.76	2.11	0.57	2.29
Interest & Investment Income	0.08	0.09	0.11	0.29	0.58	0.50	0.42	0.47	1.91	1.59
Income Tax Expense	3.58	3.52	3.58	4.65	4.81	5.78	5.48	6.46	7.13	6.69
Basic Earnings per Share	$0.73	$0.92	$0.79	$0.93	$0.96	$1.23	$0.99	$1.12	$1.13	$1.09
Weighted Average Basic Shares Outstanding	15.87M	15.86M	15.95M	16.00M	16.01M	16.00M	16.06M	16.18M	17.87M	17.01M
Diluted Earnings per Share	$0.71	$0.90	$0.78	$0.91	$0.95	$1.19	$0.97	$1.10	$1.10	$1.06
Weighted Average Diluted Shares Outstanding	16.18M	16.18M	16.30M	16.28M	16.29M	16.31M	16.37M	16.50M	18.26M	17.38M
Weighted Average Basic & Diluted Shares Outstanding	16.11M	16.13M	16.20M	16.21M	16.21M	16.23M	16.37M	18.10M	18.13M	18.17M

This table details how cash moves in and out of Addus HomeCare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-2.20	-9.26	3.91	46	17	41	33	24	-89	-15	34
Net Cash From Operating Activities	7.03	4.11	-0.74	53	33	12	109	39	105	112	116
Net Cash From Continuing Operating Activities	7.03	4.11	-0.74	53	33	12	109	39	105	112	116
Net Income / (Loss) Continuing Operations	12	12	12	12	16	25	33	45	46	63	74
Consolidated Net Income / (Loss)	12	12	12	12	16	25	33	45	46	63	74
Depreciation Expense	3.83	4.72	6.65	6.66	8.64	11	12	14	14	14	14
Amortization Expense	0.15	0.10	0.36	1.87	0.61	0.72	0.74	0.80	0.86	0.86	1.05
Non-Cash Adjustments To Reconcile Net Income	3.65	6.01	11	9.99	4.42	6.11	28	-18	21	3.46	19
Changes in Operating Assets and Liabilities, net	-13	-18	-31	22	3.10	-31	36	-3.42	23	31	9.22
Net Cash From Investing Activities	-12	-11	-22	-24	-68	-189	-214	-42	-107	-119	-355
Net Cash From Continuing Investing Activities	-12	-11	-22	-24	-68	-189	-214	-42	-107	-119	-355
Purchase of Property, Plant & Equipment	-5.27	-2.21	-1.71	-3.62	-5.35	-4.62	-6.83	-4.65	-8.30	-9.45	-6.05
Acquisitions	-7.22	-8.51	-20	-24	-62	-184	-208	-37	-98	-110	-354
Sale of Property, Plant & Equipment	-	-	-	3.70	-	-	-	0.00	0.00	0.02	0.03
Divestitures	-	-	-	-	0.00	0.00	0.26	0.00	0.00	0.00	5.36
Net Cash From Financing Activities	3.27	-2.64	26	17	51	218	138	26	-87	-8.18	272
Net Cash From Continuing Financing Activities	3.27	-2.64	26	17	51	218	138	26	-87	-8.18	272
Repayment of Debt	-0.66	-2.22	-30	-77	-106	-1.11	-0.74	-21	-137	-119	-140
Issuance of Debt	2.90	-	52	95	80	43	135	46	47	110	233
Issuance of Common Equity	-	-	-	0.00	77	173	0.00	0.00	0.00	0.00	176
Other Financing Activities, net	1.03	-0.43	4.01	-0.27	-0.02	3.09	3.92	1.11	2.55	0.32	3.44
Cash Interest Paid	0.70	0.79	2.32	2.26	4.34	2.32	2.37	5.09	7.99	10	6.52
Cash Income Taxes Paid	4.47	0.91	5.09	6.73	4.10	7.30	11	18	1.48	15	26

This table details how cash moves in and out of Addus HomeCare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-15	-26	-6.42	11	-4.44	-15	12	97	50	-124
Net Cash From Operating Activities	18	24	19	42	22	30	39	19	49	10
Net Cash From Continuing Operating Activities	18	24	19	42	22	30	39	19	49	10
Net Income / (Loss) Continuing Operations	12	15	13	15	15	20	16	18	20	20
Consolidated Net Income / (Loss)	12	15	13	15	15	20	16	18	20	20
Depreciation Expense	3.44	3.49	3.45	3.38	3.62	3.68	3.47	3.40	3.45	3.21
Amortization Expense	0.22	0.22	0.22	0.22	0.22	0.22	0.22	0.22	0.21	0.41
Non-Cash Adjustments To Reconcile Net Income	7.37	-5.37	0.45	1.75	0.63	0.64	11	2.57	3.81	2.03
Changes in Operating Assets and Liabilities, net	-4.25	11	2.02	21	1.91	5.94	8.54	-5.46	21	-15
Net Cash From Investing Activities	-1.33	-19	-1.74	-0.97	-111	-5.30	-1.75	3.55	-1.92	-354
Net Cash From Continuing Investing Activities	-1.33	-19	-1.74	-0.97	-111	-5.30	-1.75	3.55	-1.92	-354
Purchase of Property, Plant & Equipment	-1.33	-5.44	-0.78	-0.99	-2.36	-5.32	-1.35	-1.07	-1.93	-1.70
Acquisitions	-	-14	-0.97	0.03	-109	0.00	-0.40	-	-	-354
Divestitures	-	-	-	-	-	-	-	-	-	0.76
Net Cash From Financing Activities	-32	-31	-23	-30	85	-40	-25	74	2.94	220
Net Cash From Continuing Financing Activities	-32	-31	-23	-30	85	-40	-25	74	2.94	220
Repayment of Debt	-45	-32	-24	-30	-25	-40	-25	-101	-0.04	-13
Issuance of Debt	12	-	0.00	-	110	-	0.00	-	-	233
Issuance of Common Equity	-	-	-	-	-	-	-	-	-	0.02
Other Financing Activities, net	0.74	1.26	0.03	-	-	0.29	0.00	-	2.98	0.45
Cash Interest Paid	2.19	2.40	2.31	2.11	2.95	2.89	2.53	1.96	0.31	1.72
Cash Income Taxes Paid	0.63	0.85	-0.04	6.81	3.80	4.42	0.01	14	5.45	6.82

This table presents Addus HomeCare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	181	186	230	272	348	637	893	948	938	1,024	1,413
Total Current Assets	97	94	131	156	176	269	288	324	223	200	260
Cash & Equivalents	13	4.10	8.01	54	70	112	145	169	80	65	99
Accounts Receivable	68	85	117	94	98	150	133	137	126	115	123
Prepaid Expenses	7.17	4.86	6.00	8.38	7.29	7.99	9.97	18	17	20	39
Plant, Property, & Equipment, net	7.70	8.62	6.65	7.49	11	12	20	18	21	24	25
Total Noncurrent Assets	76	83	92	109	161	355	585	605	694	800	1,128
Goodwill	64	69	73	90	135	275	469	504	583	663	971
Intangible Assets	10	10	15	17	24	57	72	64	72	92	110
Other Noncurrent Operating Assets	0.27	1.34	-	-	0.00	21	38	36	39	45	47
Total Liabilities & Shareholders' Equity	181	186	230	272	348	637	893	948	938	1,024	1,413
Total Liabilities	53	44	72	95	80	161	374	373	304	318	442
Total Current Liabilities	43	42	50	55	62	88	144	118	131	145	156
Short-Term Debt	0.99	1.11	2.53	3.10	0.06	0.73	0.97	0.00	0.00	0.00	0.00
Accounts Payable	3.95	4.75	4.49	7.38	12	20	24	19	22	26	27
Accrued Expenses	37	35	43	45	34	53	73	81	72	90	91
Current Employee Benefit Liabilities	-	-	-	-	15	14	14	13	13	12	14
Other Current Liabilities	1.00	1.25	-	-	-	0.00	32	4.17	24	17	24
Total Noncurrent Liabilities	9.64	1.88	22	40	18	74	230	256	173	173	286
Long-Term Debt	-	1.88	22	40	17	59	194	221	132	124	218
Noncurrent Deferred & Payable Income Tax Liabilities	5.85	-	-	-	-	-	-	0.00	0.00	8.53	26
Other Noncurrent Operating Liabilities	1.12	-	-	0.45	0.88	14	36	35	42	40	42
Total Equity & Noncontrolling Interests	128	142	158	176	268	476	519	574	634	707	970
Total Preferred & Common Equity	128	142	158	176	268	476	519	574	634	707	970
Total Common Equity	128	142	158	176	268	476	519	574	634	707	970
Common Stock	85	87	92	96	178	360	370	380	393	404	594
Retained Earnings	43	55	65	80	91	116	149	194	240	303	376

This table presents Addus HomeCare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	946	931	928	1,036	1,014	1,117	1,153
Total Current Assets	240	209	208	211	192	295	333
Cash & Equivalents	106	74	84	80	77	173	223
Accounts Receivable	126	125	104	121	105	109	97
Prepaid Expenses	8.25	10	19	10	10	12	13
Plant, Property, & Equipment, net	17	20	20	21	24	23	24
Total Noncurrent Assets	688	702	701	804	798	798	796
Goodwill	575	584	584	663	663	664	664
Intangible Assets	73	71	69	94	90	88	87
Other Noncurrent Operating Assets	41	47	48	47	45	46	46
Total Liabilities & Shareholders' Equity	946	931	928	1,036	1,014	1,117	1,153
Total Liabilities	331	282	262	351	289	195	205
Total Current Liabilities	128	125	134	140	142	148	158
Accounts Payable	20	22	21	21	22	20	28
Accrued Expenses	75	68	80	87	83	91	92
Current Employee Benefit Liabilities	13	13	12	12	12	12	13
Other Current Liabilities	21	22	21	19	25	24	25
Total Noncurrent Liabilities	203	158	128	212	147	47	47
Long-Term Debt	164	108	79	164	99	0.00	0.00
Other Noncurrent Operating Liabilities	39	49	49	48	48	47	47
Total Equity & Noncontrolling Interests	615	649	666	684	725	922	948
Total Preferred & Common Equity	615	649	666	684	725	922	948
Total Common Equity	615	649	666	684	725	922	948
Common Stock	389	396	399	401	406	585	591
Retained Earnings	226	253	268	283	319	337	357

This table displays calculated financial ratios and metrics derived from Addus HomeCare's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	17.67%	7.63%	19.04%	6.25%	21.28%	25.58%	17.88%	13.04%	10.02%	11.31%	9.06%
EBITDA Growth	24.00%	-5.52%	8.87%	49.87%	-5.66%	43.54%	24.44%	41.78%	2.98%	26.64%	10.69%
EBIT Growth	16.88%	-11.33%	-2.13%	62.42%	-10.38%	52.24%	28.07%	48.15%	4.25%	32.32%	12.90%
NOPAT Growth	7.86%	-4.25%	-2.95%	22.53%	28.90%	48.22%	30.02%	40.12%	6.73%	32.98%	8.80%
Net Income Growth	-36.05%	-5.06%	4.62%	-1.70%	37.48%	53.58%	31.29%	36.20%	1.99%	35.83%	17.73%
EPS Growth	-36.42%	-5.45%	2.88%	-3.74%	29.13%	33.08%	17.51%	35.10%	1.07%	34.86%	10.44%
Operating Cash Flow Growth	-74.34%	-41.58%	-118.10%	7,202.42%	-37.08%	-63.80%	810.32%	-63.91%	166.18%	6.79%	3.73%
Free Cash Flow Firm Growth	-132.72%	-38.77%	-116.14%	199.57%	-240.48%	-473.73%	39.60%	92.12%	25.67%	-67.87%	-2,202.93%
Invested Capital Growth	20.50%	19.05%	24.44%	-4.80%	30.12%	96.76%	34.15%	10.18%	9.42%	11.77%	42.29%
Revenue Q/Q Growth	4.25%	0.63%	5.01%	2.00%	5.29%	9.11%	0.48%	3.43%	2.41%	2.85%	1.83%
EBITDA Q/Q Growth	12.06%	-9.33%	33.25%	-2.73%	-3.33%	29.41%	-4.73%	11.52%	1.27%	7.45%	-1.12%
EBIT Q/Q Growth	10.83%	-12.20%	48.55%	-4.33%	-5.10%	35.97%	-5.95%	13.11%	2.16%	8.54%	-1.02%
NOPAT Q/Q Growth	4.33%	-4.18%	27.31%	-24.63%	16.43%	33.69%	-5.45%	11.51%	5.29%	7.37%	-1.95%
Net Income Q/Q Growth	33.00%	-4.92%	56.36%	-33.86%	13.95%	39.45%	-6.46%	11.38%	3.84%	8.35%	-0.07%
EPS Q/Q Growth	37.50%	-4.59%	55.07%	-34.39%	10.83%	33.08%	-7.56%	11.07%	2.90%	8.19%	-2.98%
Operating Cash Flow Q/Q Growth	-28.87%	-50.07%	-102.82%	386.64%	-4.79%	-27.63%	41.66%	-21.65%	-0.86%	5.41%	-14.43%
Free Cash Flow Firm Q/Q Growth	56.85%	-992.96%	-2,727.78%	244.23%	13.18%	-271.42%	-53.98%	95.29%	-279.90%	64.85%	-304.39%
Invested Capital Q/Q Growth	4.94%	11.58%	28.71%	-2.33%	-2.79%	45.83%	42.50%	0.00%	1.87%	-0.32%	50.39%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	26.76%	25.83%	24.68%	27.20%	26.48%	27.63%	29.58%	31.21%	31.51%	32.10%	32.48%
EBITDA Margin	7.05%	6.19%	5.66%	7.98%	6.21%	7.10%	7.49%	9.40%	8.80%	10.01%	10.16%
Operating Margin	5.77%	4.76%	3.86%	5.93%	4.42%	5.36%	5.82%	7.63%	7.23%	8.59%	8.89%
EBIT Margin	5.77%	4.76%	3.91%	5.98%	4.42%	5.36%	5.82%	7.63%	7.23%	8.59%	8.89%
Profit (Net Income) Margin	3.91%	3.45%	3.03%	2.81%	3.18%	3.89%	4.33%	5.22%	4.84%	5.91%	6.37%
Tax Burden Percent	70.40%	76.04%	75.24%	56.75%	80.54%	76.08%	79.00%	74.71%	76.49%	76.87%	74.08%
Interest Burden Percent	96.24%	95.39%	103.06%	82.70%	89.38%	95.45%	94.24%	91.60%	87.54%	89.41%	96.75%
Effective Tax Rate	31.21%	25.72%	25.36%	43.95%	20.08%	22.19%	21.00%	25.29%	23.51%	23.13%	25.92%
Return on Invested Capital (ROIC)	11.58%	9.26%	7.37%	8.34%	9.58%	8.46%	7.09%	8.25%	8.02%	9.63%	8.20%
ROIC Less NNEP Spread (ROIC-NNEP)	12.96%	13.68%	16.01%	-74.63%	15.25%	11.90%	206.92%	0.12%	-4.60%	-3.69%	5.43%
Return on Net Nonoperating Assets (RNNOA)	-1.45%	-0.64%	0.75%	-1.19%	-2.19%	-1.68%	-0.42%	0.01%	-0.40%	-0.31%	0.58%
Return on Equity (ROE)	10.13%	8.62%	8.12%	7.16%	7.39%	6.78%	6.66%	8.26%	7.62%	9.33%	8.78%
Cash Return on Invested Capital (CROIC)	-7.02%	-8.13%	-14.41%	13.26%	-16.60%	-56.75%	-22.08%	-1.44%	-0.98%	-1.48%	-26.71%
Operating Return on Assets (OROA)	10.48%	8.74%	7.55%	10.16%	7.37%	7.06%	5.82%	7.17%	7.29%	9.27%	8.43%
Return on Assets (ROA)	7.10%	6.34%	5.85%	4.77%	5.30%	5.13%	4.33%	4.90%	4.88%	6.37%	6.04%
Return on Common Equity (ROCE)	10.13%	8.62%	8.12%	7.16%	7.39%	6.78%	6.66%	8.26%	7.62%	9.33%	8.78%
Return on Equity Simple (ROE_SIMPLE)	9.57%	8.20%	7.71%	6.78%	6.12%	5.31%	6.39%	7.86%	7.26%	8.85%	7.58%
Net Operating Profit after Tax (NOPAT)	12	12	12	14	18	27	35	49	53	70	76
NOPAT Margin	3.97%	3.53%	2.88%	3.32%	3.53%	4.17%	4.60%	5.70%	5.53%	6.60%	6.59%
Net Nonoperating Expense Percent (NNEP)	-1.39%	-4.42%	-8.65%	82.97%	-5.67%	-3.44%	-199.83%	8.13%	12.62%	13.32%	2.76%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	6.87%	8.42%	6.40%
Cost of Revenue to Revenue	73.24%	74.17%	75.32%	72.80%	73.52%	72.37%	70.42%	68.79%	68.49%	67.90%	67.52%
SG&A Expenses to Revenue	19.76%	19.64%	19.17%	18.05%	20.39%	20.64%	22.19%	21.91%	22.81%	22.18%	22.41%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	20.98%	21.08%	20.82%	21.27%	22.06%	22.27%	23.76%	23.59%	24.29%	23.51%	23.59%
Earnings before Interest and Taxes (EBIT)	18	16	16	25	23	35	45	66	69	91	103
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	22	21	23	34	32	46	57	81	84	106	117
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.08	1.82	2.55	2.30	3.31	3.18	3.57	2.59	2.53	2.13	2.34
Price to Tangible Book Value (P/TBV)	5.00	4.14	5.76	5.83	8.14	10.57	0.00	264.50	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.85	0.77	1.00	0.95	1.72	2.33	2.42	1.72	1.69	1.42	1.97
Price to Earnings (P/E)	21.79	22.25	33.04	33.86	54.11	59.94	55.87	33.00	34.83	24.08	30.88
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.59%	4.49%	3.03%	2.95%	1.85%	1.67%	1.79%	3.03%	2.87%	4.15%	3.24%
Enterprise Value to Invested Capital (EV/IC)	2.18	1.84	2.40	2.38	3.88	3.45	3.34	2.46	2.41	2.04	2.19
Enterprise Value to Revenue (EV/Rev)	0.82	0.76	1.04	0.92	1.62	2.25	2.49	1.78	1.74	1.48	2.07
Enterprise Value to EBITDA (EV/EBITDA)	11.61	12.31	18.42	11.59	26.06	31.73	33.18	18.97	19.78	14.77	20.40
Enterprise Value to EBIT (EV/EBIT)	14.17	16.01	26.65	15.47	36.62	42.04	42.71	23.38	24.07	17.20	23.30
Enterprise Value to NOPAT (EV/NOPAT)	20.60	21.56	36.18	27.84	45.82	54.02	54.06	31.29	31.47	22.38	31.45
Enterprise Value to Operating Cash Flow (EV/OCF)	36.44	62.49	0.00	7.47	25.18	121.55	17.37	39.03	15.74	13.94	20.55
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	17.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.03	0.02	0.16	0.24	0.06	0.13	0.38	0.38	0.21	0.18	0.23
Long-Term Debt to Equity	0.02	0.01	0.14	0.23	0.06	0.12	0.37	0.38	0.21	0.18	0.23
Financial Leverage	-0.11	-0.05	0.05	0.02	-0.14	-0.14	0.00	0.09	0.09	0.08	0.11
Leverage Ratio	1.43	1.36	1.39	1.50	1.39	1.32	1.54	1.68	1.56	1.46	1.45
Compound Leverage Factor	1.37	1.30	1.43	1.24	1.25	1.26	1.45	1.54	1.37	1.31	1.41
Debt to Total Capital	2.78%	2.07%	13.69%	19.59%	6.05%	11.18%	27.31%	27.78%	17.22%	14.94%	18.37%
Short-Term Debt to Total Capital	0.75%	0.77%	1.38%	1.41%	0.02%	0.14%	0.14%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	2.03%	1.30%	12.30%	18.18%	6.03%	11.05%	27.17%	27.78%	17.22%	14.94%	18.37%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	97.22%	97.93%	86.31%	80.41%	93.95%	88.82%	72.69%	72.22%	82.78%	85.06%	81.63%
Debt to EBITDA	0.17	0.14	1.10	1.26	0.54	1.30	3.40	2.72	1.58	1.17	1.86
Net Debt to EBITDA	-0.48	-0.10	0.71	-0.32	-1.66	-1.13	0.87	0.64	0.62	0.56	1.02
Long-Term Debt to EBITDA	0.12	0.09	0.99	1.17	0.54	1.29	3.38	2.72	1.58	1.17	1.86
Debt to NOPAT	0.29	0.25	2.17	3.04	0.95	2.21	5.54	4.48	2.51	1.78	2.87
Net Debt to NOPAT	-0.85	-0.17	1.39	-0.76	-2.91	-1.92	1.42	1.06	0.99	0.85	1.57
Long-Term Debt to NOPAT	0.22	0.16	1.95	2.82	0.94	2.19	5.51	4.48	2.51	1.78	2.87
Altman Z-Score	5.78	6.36	6.14	5.28	9.16	7.43	4.42	4.08	4.89	4.65	4.60
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.25	2.23	2.64	2.83	2.86	3.08	2.00	2.76	1.70	1.38	1.67
Quick Ratio	1.89	2.11	2.52	2.67	2.74	2.99	1.93	2.60	1.57	1.24	1.42
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-7.53	-10	-23	23	-32	-181	-110	-8.63	-6.41	-11	-248
Operating Cash Flow to CapEx	133.26%	185.54%	-43.40%	0.00%	620.73%	260.10%	1,601.68%	850.12%	1,266.39%	1,189.18%	1,933.80%
Free Cash Flow to Firm to Interest Expense	-10.79	-13.30	-9.69	5.03	-6.30	-58.41	-34.35	-1.49	-0.72	-0.97	-32.06
Operating Cash Flow to Interest Expense	10.07	5.22	-0.32	11.80	6.62	3.87	34.31	6.80	11.80	10.11	15.06
Operating Cash Flow Less CapEx to Interest Expense	2.51	2.41	-1.05	11.82	5.55	2.38	32.17	6.00	10.87	9.26	14.28
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.82	1.84	1.93	1.70	1.67	1.32	1.00	0.94	1.01	1.08	0.95
Accounts Receivable Turnover	4.83	4.39	3.97	4.05	5.39	5.23	5.42	6.41	7.25	8.79	9.69
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	60.59	41.29	52.52	60.27	56.94	56.88	47.94	45.22	47.96	46.85	47.40
Accounts Payable Turnover	53.40	57.43	65.40	52.27	38.72	29.46	24.85	27.62	31.43	29.78	29.22
Days Sales Outstanding (DSO)	75.63	83.06	91.93	90.19	67.77	69.76	67.37	56.91	50.36	41.55	37.68
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	6.83	6.36	5.58	6.98	9.43	12.39	14.69	13.22	11.61	12.26	12.49
Cash Conversion Cycle (CCC)	68.80	76.70	86.35	83.21	58.34	57.37	52.68	43.70	38.75	29.29	25.19
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	117	140	174	166	215	424	568	626	685	766	1,090
Invested Capital Turnover	2.91	2.62	2.56	2.51	2.71	2.03	1.54	1.45	1.45	1.46	1.24
Increase / (Decrease) in Invested Capital	20	22	34	-8.35	50	208	145	58	59	81	324
Enterprise Value (EV)	256	257	418	394	836	1,461	1,901	1,541	1,655	1,565	2,393
Market Capitalization	267	259	402	405	889	1,513	1,851	1,489	1,603	1,506	2,273
Book Value per Share	$11.64	$12.76	$13.76	$15.16	$20.50	$30.57	$32.81	$36.06	$39.33	$43.58	$53.52
Tangible Book Value per Share	$4.86	$5.63	$6.09	$5.96	$8.34	$9.20	($1.39)	$0.35	($1.33)	($2.98)	($6.05)
Total Capital	132	145	183	219	286	535	714	795	765	831	1,189
Total Debt	3.66	2.99	25	43	17	60	195	221	132	124	218
Total Long-Term Debt	2.68	1.88	22	40	17	59	194	221	132	124	218
Net Debt	-11	-2.01	16	-11	-53	-52	50	52	52	59	120
Capital Expenditures (CapEx)	5.27	2.21	1.71	-0.09	5.35	4.62	6.83	4.65	8.30	9.44	6.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)	42	49	76	50	44	71	-0.31	38	12	-9.90	5.60
Debt-free Net Working Capital (DFNWC)	55	53	84	104	115	183	145	207	92	55	105
Net Working Capital (NWC)	54	52	81	101	115	182	144	207	92	55	105
Net Nonoperating Expense (NNE)	0.19	0.28	-0.61	2.20	1.81	1.81	2.03	4.14	6.55	7.40	2.47
Net Nonoperating Obligations (NNO)	-11	-2.01	16	-11	-53	-52	50	52	52	59	120
Total Depreciation and Amortization (D&A)	3.98	4.81	7.00	8.53	9.25	11	13	15	15	15	15
Debt-free, Cash-free Net Working Capital to Revenue	13.35%	14.47%	18.93%	11.72%	8.55%	10.92%	-0.04%	4.37%	1.23%	-0.94%	0.49%
Debt-free Net Working Capital to Revenue	17.62%	15.69%	20.93%	24.34%	22.18%	28.14%	18.93%	23.90%	9.64%	5.18%	9.05%
Net Working Capital to Revenue	17.31%	15.36%	20.30%	23.61%	22.16%	28.03%	18.80%	23.90%	9.64%	5.18%	9.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.12	$1.06	$1.06	$1.19	$1.45	$1.83	$2.12	$2.87	$2.90	$3.91	$4.33
Adjusted Weighted Average Basic Shares Outstanding	10.90M	10.99M	11.29M	11.47M	12.05M	13.82M	15.60M	15.74M	15.86M	16.00M	17.01M
Adjusted Diluted Earnings per Share	$1.10	$1.04	$1.06	$1.17	$1.41	$1.77	$2.08	$2.81	$2.84	$3.83	$4.23
Adjusted Weighted Average Diluted Shares Outstanding	11.11M	11.19M	11.35M	11.62M	12.38M	14.25M	15.96M	16.06M	16.18M	16.31M	17.38M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	11.01M	11.12M	11.53M	11.63M	13.18M	13.82M	15.83M	15.95M	16.13M	16.23M	18.17M
Normalized Net Operating Profit after Tax (NOPAT)	12	12	12	14	18	27	35	49	53	70	76
Normalized NOPAT Margin	3.97%	3.53%	2.88%	3.32%	3.53%	4.17%	4.60%	5.70%	5.53%	6.60%	6.59%
Pre Tax Income Margin	5.56%	4.54%	4.03%	4.94%	3.95%	5.11%	5.48%	6.99%	6.33%	7.68%	8.61%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	25.89	20.39	6.72	5.70	4.55	11.19	13.96	11.36	7.72	8.19	13.28
NOPAT to Interest Expense	17.81	15.14	4.95	3.17	3.64	8.71	11.03	8.49	5.90	6.30	9.84
EBIT Less CapEx to Interest Expense	18.33	17.57	5.99	5.71	3.48	9.70	11.81	10.56	6.79	7.34	12.50
NOPAT Less CapEx to Interest Expense	10.25	12.33	4.22	3.18	2.57	7.22	8.88	7.68	4.97	5.45	9.06
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Addus HomeCare's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	11.00%	9.98%	11.02%	9.72%	12.57%	11.86%	11.58%	10.36%	7.04%	7.52%
EBITDA Growth	0.88%	4.46%	29.11%	21.32%	25.99%	29.95%	22.72%	18.54%	11.02%	-4.17%
EBIT Growth	0.90%	7.52%	37.70%	27.50%	30.39%	34.38%	27.07%	21.55%	13.63%	-3.78%
NOPAT Growth	4.97%	18.53%	48.99%	29.62%	30.23%	28.48%	21.04%	17.56%	10.17%	-7.19%
Net Income Growth	-0.29%	13.05%	49.65%	32.02%	33.51%	32.62%	24.89%	21.73%	30.84%	-0.27%
EPS Growth	-1.39%	9.76%	47.17%	30.00%	33.80%	32.22%	24.36%	20.88%	15.79%	-10.92%
Operating Cash Flow Growth	4.02%	-3.61%	214.21%	-26.37%	18.94%	23.70%	105.75%	-54.79%	122.75%	-65.33%
Free Cash Flow Firm Growth	84.63%	3.50%	144.19%	148.64%	-137.37%	-40.08%	-196.97%	-321.83%	180.28%	-414.41%
Invested Capital Growth	7.40%	9.42%	-4.65%	-2.12%	14.23%	11.77%	9.35%	13.24%	-5.69%	42.29%
Revenue Q/Q Growth	1.50%	2.73%	1.84%	3.33%	4.13%	2.08%	1.59%	2.20%	1.00%	2.54%
EBITDA Q/Q Growth	2.19%	15.80%	-9.17%	12.87%	6.12%	19.45%	-14.23%	9.03%	-0.62%	3.10%
EBIT Q/Q Growth	3.68%	18.83%	-10.60%	15.75%	6.04%	22.47%	-15.46%	10.73%	-0.87%	3.70%
NOPAT Q/Q Growth	5.60%	25.78%	-13.68%	13.05%	6.10%	24.08%	-18.68%	9.81%	-0.57%	4.53%
Net Income Q/Q Growth	2.60%	27.89%	-14.14%	17.18%	3.76%	27.04%	-19.14%	14.21%	11.53%	-3.16%
EPS Q/Q Growth	1.43%	26.76%	-13.33%	16.67%	4.40%	25.26%	-18.49%	13.40%	0.00%	-3.64%
Operating Cash Flow Q/Q Growth	-67.59%	32.63%	-22.61%	121.36%	-47.65%	37.93%	28.72%	-51.36%	157.93%	-78.53%
Free Cash Flow Firm Q/Q Growth	47.78%	-27.80%	213.38%	-35.72%	-354.84%	24.58%	21.51%	-47.05%	192.23%	-583.25%
Invested Capital Q/Q Growth	-0.36%	1.87%	-0.22%	-3.36%	16.29%	-0.32%	-2.38%	0.08%	-3.15%	50.39%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	31.26%	31.88%	31.17%	31.66%	32.04%	33.44%	31.41%	32.47%	31.82%	34.15%
EBITDA Margin	8.80%	9.92%	8.85%	9.67%	9.85%	11.53%	9.73%	10.39%	10.22%	10.28%
Operating Margin	7.28%	8.43%	7.40%	8.28%	8.44%	10.12%	8.42%	9.12%	8.96%	9.06%
EBIT Margin	7.28%	8.43%	7.40%	8.28%	8.44%	10.12%	8.42%	9.12%	8.96%	9.06%
Profit (Net Income) Margin	4.80%	5.98%	5.04%	5.71%	5.69%	7.08%	5.64%	6.30%	6.96%	6.57%
Tax Burden Percent	76.31%	80.77%	77.99%	76.17%	76.22%	77.22%	74.28%	73.67%	73.89%	74.49%
Interest Burden Percent	86.36%	87.81%	87.34%	90.53%	88.53%	90.65%	90.12%	93.74%	105.14%	97.41%
Effective Tax Rate	23.69%	19.23%	22.01%	23.83%	23.78%	22.78%	25.72%	26.33%	26.11%	25.51%
Return on Invested Capital (ROIC)	7.95%	9.87%	8.04%	9.44%	9.18%	11.40%	9.51%	10.63%	10.05%	8.39%
ROIC Less NNEP Spread (ROIC-NNEP)	5.06%	5.92%	5.83%	4.99%	6.37%	7.77%	3.48%	11.99%	8.63%	7.81%
Return on Net Nonoperating Assets (RNNOA)	0.54%	0.51%	0.79%	0.28%	0.70%	0.64%	0.15%	-1.35%	-0.73%	0.83%
Return on Equity (ROE)	8.49%	10.38%	8.82%	9.71%	9.88%	12.05%	9.65%	9.29%	9.32%	9.23%
Cash Return on Invested Capital (CROIC)	0.55%	-0.98%	12.94%	11.29%	-4.25%	-1.48%	1.26%	-1.65%	16.25%	-26.71%
Operating Return on Assets (OROA)	7.23%	8.50%	7.53%	8.75%	8.76%	10.92%	9.42%	9.95%	9.28%	8.58%
Return on Assets (ROA)	4.77%	6.03%	5.13%	6.03%	5.91%	7.64%	6.31%	6.87%	7.21%	6.23%
Return on Common Equity (ROCE)	8.49%	10.38%	8.82%	9.71%	9.88%	12.05%	9.65%	9.29%	9.32%	9.23%
Return on Equity Simple (ROE_SIMPLE)	7.21%	0.00%	7.74%	8.08%	8.43%	0.00%	9.06%	7.48%	7.77%	0.00%
Net Operating Profit after Tax (NOPAT)	13	17	15	16	17	22	18	19	19	20
NOPAT Margin	5.56%	6.80%	5.77%	6.31%	6.43%	7.82%	6.26%	6.72%	6.62%	6.75%
Net Nonoperating Expense Percent (NNEP)	2.89%	3.95%	2.21%	4.44%	2.81%	3.63%	6.03%	-1.35%	1.42%	0.58%
Return On Investment Capital (ROIC_SIMPLE)	-	2.20%	-	-	-	2.60%	-	-	-	1.69%
Cost of Revenue to Revenue	68.74%	68.12%	68.83%	68.34%	67.96%	66.56%	68.59%	67.53%	68.18%	65.85%
SG&A Expenses to Revenue	22.55%	22.05%	22.40%	22.08%	22.26%	21.99%	21.75%	22.16%	21.67%	24.01%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.98%	23.46%	23.77%	23.38%	23.60%	23.32%	22.99%	23.34%	22.86%	25.10%
Earnings before Interest and Taxes (EBIT)	18	21	19	22	23	28	24	26	26	27
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	21	25	22	25	27	32	27	30	30	31
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.49	2.53	2.65	2.25	2.02	2.13	2.31	2.06	2.54	2.34
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	108.57	0.00	0.00	0.00	11.22	12.20	0.00
Price to Revenue (P/Rev)	1.65	1.69	1.76	1.50	1.34	1.42	1.54	1.71	2.12	1.97
Price to Earnings (P/E)	34.55	34.83	34.28	27.90	23.94	24.08	25.52	27.59	32.69	30.88
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.89%	2.87%	2.92%	3.58%	4.18%	4.15%	3.92%	3.62%	3.06%	3.24%
Enterprise Value to Invested Capital (EV/IC)	2.36	2.41	2.57	2.26	1.91	2.04	2.27	2.31	3.01	2.19
Enterprise Value to Revenue (EV/Rev)	1.71	1.74	1.80	1.50	1.42	1.48	1.56	1.55	1.93	2.07
Enterprise Value to EBITDA (EV/EBITDA)	19.24	19.78	19.81	16.08	14.86	14.77	15.30	14.94	18.42	20.40
Enterprise Value to EBIT (EV/EBIT)	23.62	24.07	23.79	19.07	17.49	17.20	17.69	17.17	21.06	23.30
Enterprise Value to NOPAT (EV/NOPAT)	31.83	31.47	30.64	24.50	22.50	22.38	23.27	22.78	28.16	31.45
Enterprise Value to Operating Cash Flow (EV/OCF)	14.99	15.74	14.90	14.53	13.76	13.94	12.85	15.80	16.06	20.55
Enterprise Value to Free Cash Flow (EV/FCFF)	445.87	0.00	19.38	19.84	0.00	0.00	187.95	0.00	18.01	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.27	0.21	0.17	0.12	0.24	0.18	0.14	0.00	0.00	0.23
Long-Term Debt to Equity	0.27	0.21	0.17	0.12	0.24	0.18	0.14	0.00	0.00	0.23
Financial Leverage	0.11	0.09	0.13	0.06	0.11	0.08	0.04	-0.11	-0.09	0.11
Leverage Ratio	1.60	1.56	1.55	1.50	1.53	1.46	1.42	1.29	1.34	1.45
Compound Leverage Factor	1.38	1.37	1.36	1.35	1.35	1.33	1.28	1.21	1.41	1.42
Debt to Total Capital	21.01%	17.22%	14.32%	10.56%	19.32%	14.94%	12.05%	0.00%	0.00%	18.37%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	21.01%	17.22%	14.32%	10.56%	19.32%	14.94%	12.05%	0.00%	0.00%	18.37%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	78.99%	82.78%	85.68%	89.44%	80.68%	85.06%	87.95%	100.00%	100.00%	81.63%
Debt to EBITDA	1.98	1.58	1.22	0.85	1.66	1.17	0.90	0.00	0.00	1.86
Net Debt to EBITDA	0.70	0.62	0.39	-0.06	0.85	0.56	0.20	0.00	0.00	1.02
Long-Term Debt to EBITDA	1.98	1.58	1.22	0.85	1.66	1.17	0.90	0.00	0.00	1.86
Debt to NOPAT	3.28	2.51	1.89	1.29	2.52	1.78	1.36	0.00	0.00	2.87
Net Debt to NOPAT	1.16	0.99	0.61	-0.09	1.29	0.85	0.31	0.00	0.00	1.57
Long-Term Debt to NOPAT	3.28	2.51	1.89	1.29	2.52	1.78	1.36	0.00	0.00	2.87
Altman Z-Score	4.29	4.72	5.26	5.09	3.89	4.44	5.13	7.51	8.71	4.43
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.87	1.70	1.68	1.55	1.51	1.38	1.35	2.00	2.11	1.67
Quick Ratio	1.81	1.57	1.60	1.41	1.44	1.24	1.28	1.91	2.02	1.42
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-33	-42	48	31	-78	-59	-46	-68	63	-304
Operating Cash Flow to CapEx	1,381.30%	446.87%	2,419.43%	4,186.52%	921.92%	566.43%	2,865.04%	1,756.58%	2,524.71%	613.91%
Free Cash Flow to Firm to Interest Expense	-13.35	-16.04	19.43	13.19	-24.49	-18.97	-16.82	-32.26	109.77	-132.90
Operating Cash Flow to Interest Expense	7.41	9.24	7.64	17.85	6.81	9.65	14.02	8.90	84.69	4.56
Operating Cash Flow Less CapEx to Interest Expense	6.87	7.17	7.32	17.43	6.07	7.94	13.53	8.39	81.33	3.81
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.99	1.01	1.02	1.06	1.04	1.08	1.12	1.09	1.04	0.95
Accounts Receivable Turnover	7.14	7.25	7.44	8.73	8.32	8.79	9.45	10.45	10.42	9.69
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	51.53	47.96	49.65	53.52	54.26	46.85	49.31	51.86	51.27	47.40
Accounts Payable Turnover	29.73	31.43	31.25	32.56	34.37	29.78	33.72	36.90	31.28	29.22
Days Sales Outstanding (DSO)	51.11	50.36	49.03	41.79	43.86	41.55	38.62	34.94	35.04	37.68
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	12.28	11.61	11.68	11.21	10.62	12.26	10.82	9.89	11.67	12.49
Cash Conversion Cycle (CCC)	38.83	38.75	37.35	30.58	33.24	29.29	27.79	25.05	23.37	25.19
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	673	685	684	661	769	766	748	748	725	1,090
Invested Capital Turnover	1.43	1.45	1.39	1.50	1.43	1.46	1.52	1.58	1.52	1.24
Increase / (Decrease) in Invested Capital	46	59	-33	-14	96	81	64	87	-44	324
Enterprise Value (EV)	1,589	1,655	1,757	1,497	1,465	1,565	1,698	1,727	2,185	2,393
Market Capitalization	1,531	1,603	1,722	1,502	1,381	1,506	1,676	1,901	2,408	2,273
Book Value per Share	$38.24	$39.33	$40.23	$41.12	$42.20	$43.58	$45.14	$56.30	$52.35	$53.52
Tangible Book Value per Share	($2.05)	($1.33)	($0.35)	$0.85	($4.47)	($2.98)	($1.77)	$10.35	$10.91	($6.05)
Total Capital	778	765	757	745	848	831	824	922	948	1,189
Total Debt	164	132	108	79	164	124	99	0.00	0.00	218
Total Long-Term Debt	164	132	108	79	164	124	99	0.00	0.00	218
Net Debt	58	52	35	-5.49	84	59	23	-173	-223	120
Capital Expenditures (CapEx)	1.33	5.44	0.78	0.99	2.36	5.31	1.35	1.07	1.92	1.70
Debt-free, Cash-free Net Working Capital (DFCFNWC)	6.31	12	11	-10	-8.14	-9.90	-26	-26	-48	5.60
Debt-free Net Working Capital (DFNWC)	112	92	85	74	72	55	50	147	175	105
Net Working Capital (NWC)	112	92	85	74	72	55	50	147	175	105
Net Nonoperating Expense (NNE)	1.82	2.05	1.84	1.55	2.00	2.02	1.73	1.21	-0.99	0.52
Net Nonoperating Obligations (NNO)	58	52	35	-5.49	84	59	23	-173	-223	120
Total Depreciation and Amortization (D&A)	3.66	3.70	3.66	3.60	3.84	3.89	3.68	3.62	3.66	3.62
Debt-free, Cash-free Net Working Capital to Revenue	0.68%	1.23%	1.13%	-1.03%	-0.79%	-0.94%	-2.43%	-2.32%	-4.22%	0.49%
Debt-free Net Working Capital to Revenue	12.05%	9.64%	8.66%	7.40%	6.96%	5.18%	4.62%	13.23%	15.43%	9.05%
Net Working Capital to Revenue	12.05%	9.64%	8.66%	7.40%	6.96%	5.18%	4.62%	13.23%	15.43%	9.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.73	$0.92	$0.79	$0.93	$0.96	$1.23	$0.99	$1.12	$1.13	$1.09
Adjusted Weighted Average Basic Shares Outstanding	15.87M	15.86M	15.95M	16.00M	16.01M	16.00M	16.06M	16.18M	17.87M	17.01M
Adjusted Diluted Earnings per Share	$0.71	$0.90	$0.78	$0.91	$0.95	$1.19	$0.97	$1.10	$1.10	$1.06
Adjusted Weighted Average Diluted Shares Outstanding	16.18M	16.18M	16.30M	16.28M	16.29M	16.31M	16.37M	16.50M	18.26M	17.38M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	16.11M	16.13M	16.20M	16.21M	16.21M	16.23M	16.37M	18.10M	18.13M	18.17M
Normalized Net Operating Profit after Tax (NOPAT)	13	17	15	16	17	22	18	19	19	20
Normalized NOPAT Margin	5.56%	6.80%	5.77%	6.31%	6.43%	7.82%	6.26%	6.72%	6.62%	6.75%
Pre Tax Income Margin	6.29%	7.40%	6.46%	7.50%	7.47%	9.17%	7.59%	8.55%	9.42%	8.82%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.09	7.92	7.56	9.24	7.14	8.98	8.57	12.38	45.29	11.77
NOPAT to Interest Expense	5.41	6.39	5.90	7.04	5.44	6.93	6.37	9.12	33.47	8.77
EBIT Less CapEx to Interest Expense	6.55	5.85	7.25	8.81	6.40	7.28	8.08	11.88	41.94	11.03
NOPAT Less CapEx to Interest Expense	4.87	4.33	5.58	6.61	4.70	5.23	5.88	8.62	30.11	8.02
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Addus HomeCare's Financials

When does Addus HomeCare's financial year end?

According to the most recent income statement we have on file, Addus HomeCare's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Addus HomeCare's net income changed over the last 10 years?

Addus HomeCare's net income appears to be on an upward trend, with a most recent value of $73.60 million in 2024, rising from $12.24 million in 2014. The previous period was $62.52 million in 2023.

What is Addus HomeCare's operating income?

Addus HomeCare's total operating income in 2024 was $102.69 million, based on the following breakdown:

Total Gross Profit: $375.02 million
Total Operating Expenses: $272.33 million

How has Addus HomeCare revenue changed over the last 10 years?

Over the last 10 years, Addus HomeCare's total revenue changed from $312.94 million in 2014 to $1.15 billion in 2024, a change of 268.9%.

How much debt does Addus HomeCare have?

Addus HomeCare's total liabilities were at $442.14 million at the end of 2024, a 39.2% increase from 2023, and a 736.6% increase since 2014.

How much cash does Addus HomeCare have?

In the past 10 years, Addus HomeCare's cash and equivalents has ranged from $4.10 million in 2015 to $168.90 million in 2021, and is currently $98.91 million as of their latest financial filing in 2024.

How has Addus HomeCare's book value per share changed over the last 10 years?

Over the last 10 years, Addus HomeCare's book value per share changed from 11.64 in 2014 to 53.52 in 2024, a change of 359.7%.

Remove Ads

Related Companies

This page (NASDAQ:ADUS) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Addus HomeCare (ADUS) Financials

Frequently Asked Questions About Addus HomeCare's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Addus HomeCare (ADUS) Financials

Annual Income Statements for Addus HomeCare

Quarterly Income Statements for Addus HomeCare

Annual Cash Flow Statements for Addus HomeCare

Quarterly Cash Flow Statements for Addus HomeCare

Annual Balance Sheets for Addus HomeCare

Quarterly Balance Sheets for Addus HomeCare

Annual Metrics and Ratios for Addus HomeCare

Quarterly Metrics and Ratios for Addus HomeCare

Frequently Asked Questions About Addus HomeCare's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools